EPIGENETICS AND SOT TREATMENT FOR CHRONIC LYME DISEASE
Chronic Lyme Disease
Epigenetics is the study of the effect of genes on cells actions, and how those actions are affected by outside influences. This is the basis of the cutting-edge treatment called SOT. This treatment can help a variety of chronic infections such as Lyme’s disease, Chronic Epstein Barr, Herpes, CMV and others, in a way never before possible.
A patient’s blood is sent to a lab that specializes in epigenetics. The lab identifies the genetic sequence (gene epitope) of the bacteria or virus present in the patient. Once they recognize the genetic epitope of the target-that portion of the organisms’ cells that cause replication of the organism, they can create a treatment- the SOT (Supportive Oligonucleotide Technique) molecule.
By the intravenous administration of SOT, the genes of the infectious organism which promote replication of the organism can be turned off. That can stop the organism from multiplying, relieving the symptoms of chronic illness. This treatment specifically targets the genes of the organism. It does not interact in any way with the person’s cells; therefore, experience has shown SOT to be a very safe treatment.
SOT treatment can be explained as using a “key” for a specific “lock”. The key is the SOT molecule which fits into the lock-the specific genetic sequence of the invading organism, therefore turning off the replication of the organism. After receiving an Intravenous SOT treatment, the SOT molecule interacts with the genetic makeup of the infectious organism on a 24/7 basis to stop the symptoms of chronic illness. This therapeutic action can last for months. If needed SOT treatment may three times within a year to achieve its maximum therapeutic effectiveness.
For more information see www.drsobo.com or call 203-348-8805